EBGLYSS: payments to doctors
Payments that named EBGLYSS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13M
- Providers
- 15,213
- Transactions
- 76,258
- Average per transaction
- $170
The per-transaction average — $170 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 15,213 providers the average total is $852, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $11,968,129 | 92.3% |
| Eli Lilly | $991,499 | 7.6% |
| Eli Lilly Export S.A. Puerto Rico Branch | $3,874 | 0.0% |